Professional Documents
Culture Documents
Context
This
document
is
a
study
designed
to
obtain
a
sense
of
the
poten5al
market
for
assis5ve
aids
/
devices
(rehabilita5on
and
mobility)
for
people
with
locomotor
disability
in
India.
The
study
is
intended
to
support
ICRC’s
Enable
Make-‐a-‐thon
and
Corporate
Engagement.
1
Interna4onal
Commi7ee
of
the
Red
Cross:
Enable
Make-‐
a-‐thon
and
Corporate
Engagement
Market
Size
Assessment
Methodology
Our
methodology
for
the
study
included:
• Looking
at
the
issue
through
the
prism
of
the
eight
challenges
iden5fied
by
ICRC
• Mixed
methods
analysis,
including
secondary
research,
telephone
interviews
with
stakeholders
and
quan5ta5ve/qualita5ve
analysis
3
Execu4ve
Summary
PwD
(people
with
disability)
(total
and
locomotor)
has
widely
varying
es5mates
We
es5mate
a
disability
prevalence
rate
of
7-‐10%
of
the
total
popula5on
Within
this,
we
es5mate
a
locomotor
disability
prevalence
rate
of
close
to
40%
of
the
popula5on
with
disability
The
current
market
for
assis5ve
aids/devices
is
small
(US$
41.7m)
and
primarily
driven
by
free
distribu5on
There
is
a
large
unmet
market
es5mated
at
US$
316m
for
assis5ve
aids/devices
The
BoP
space
is
mainly
fed
by
government-‐affiliated
ins5tu5ons,
in
which
ALIMCO
is
a
major
player.
ALIMCO
manufactures
aids
and
conducts
camps
across
India
for
distribu5on.
State
governments,
other
government-‐affiliated
ins5tutes,
and
most
NGOs
procure
aids
from
ALIMCO
and
conduct
camps
for
distribu5on.
The
challenge
does
not
appear
to
be
ability
to
pay,
given
the
extent
of
free
government
distribu5on
and
CSR
support
CONCLUSION
There
is
space
for
innova5ve
products
that
can
deliver
high-‐quality
solu5ons
at
fairly
low
costs.
Sa5sfying
such
criteria
opens
up
both
Indian
and
global
markets
for
manufacturers
and
providers
4
Learnings
&
Recommenda4ons:
Low
cost/high
quality
products
are
a
clear
area
of
focus
Cost
High
Private
cos.
(O7obock,
Small
market,
Endolite
India,
mostly
imported
Ostrich
Mobility,
players
VISSCO,
etc.)
Low
High
Quality
Innova5on
in
the
low
cost,
high
quality
space
has
overcome
affordability/
price
barriers
in
the
past.
An
opportunity
exists
both
to
create
new
innova5on
and
bring
exis5ng
innova5ons
to
scale.
Microinsurance
as
a
payment
mechanism
may
be
one
op5on
5
1Dalberg
interviews
Market
sizing
approach
We
broke
our
analysis
down
into
the
following
stages:
Prevalence of Disability Type of disability Access to care Type of assis4ve aid
Splints
Total
Speech
Did
not
receive
Popula5on
medical
advice
Spinal
Braces
Developmental
Personal
mobility
aids
Without
Crutches
disability
Wheelchairs
Tricycles
6
Global
indicators:
Total
disability
1970s 2011
Sources:
World
Health
Organiza5on
(2011),
“World
Report
on
Disablity”;
United
Na5ons
Factsheet
on
Persons
with
Disabili5es
7
Icons
from
www.thenounproject.com
Global
indicators:
Total
&
locomotor
disability
Locomotor
disability
prevalence
in
other
middle
Compara4ve
data
on
total
disability
prevalence
rates1
income
countries1
(Millions
of
people,
%
of
total
popula5on)
(Millions
of
people,
%
of
total
popula5on)
46 13
9
23.9%
7%
4
83
24
12.3%
6.3%
7.5%
1.8%
1Turkey Disability Survey (2002), Communique On Major Sta5s5cs Of the Second China Na5onal Sample Survey on Disability (2008), Ins5tuto Brasileiro de
Geografia
e
Estans5ca
(2010),
Sta5s5cs
South
Africa
(2014)
“Census
2011:
Profile
of
persons
with
disability
in
South
Africa”
2Disability
prevalence
increased
from
1-‐2%
(1991)
to
14.5%
(2001)
aoer
Brazil
adopted
the
Interna5onal
Classifica5on
of
Func5oning,
Disability
and
Heath
8
(ICF)
framework.
ICF
is
the
WHO
framework
for
measuring
health
and
disability,
in
which
ques5ons
address
func5onal
capaci5es.
India
trends:
Total
disability
Compara4ve
es4mates
for
total
disability
prevalence
in
India
(Millions
of
people,
%
of
total
popula5on)
Based
on
triangula5on
of
data,
and
aoer
consulta5ons
with
NGOs
and
senior
ac5vists
we
es5mate
a
range
of
5
–
8%
for
total
disability
prevalence
in
India
1Expert
interviews,
Report
of
the
Technical
Advisory
Commiqee
on
Disability
Sta5s5cs
(2007)
and
Ministry
of
Sta5s5cs
and
Programme
Implementa5on,GoI
(2012)
“Manual
on
Disability
Sta5s5cs”;
2Na5onal
Sample
Survey,
58th
round
(2002);
3Planning
Commission,
GoI
(2008)
“Eleventh
Five
Year
Plan:
Volume
I”;
4World
Bank
(2009),
“People
with
Disabili5es
in
India:
From
Commitments
to
Outcomes”
Note:
The
Census
2011
sta5s5cs
for
disability
do
not
vary
significantly
from
Census
2001;
the
NSSO
58th
round
(2002)
focused
exclusively
on
disability,
9
therefore
in
this
study
we
have
adjusted
the
NSSO
2002
figures
to
reflect
2015
projec5ons
India
trends:
Locomotor
disability
According
to
NSS
es4mates,
prevalence
of
locomotor
disability
is
the
highest
in
India
(Millions
of
people,
%
of
disabled
popula5on)
Developmental
10% 11%
Ø Inclusion
of
dwarves
and
persons
Speech
7% 12%
with
s4ff
neck
of
permanent
nature
Hearing
6%
17%
in
NSS
methodology
results
in
a
much
higher
prevalence
of
locomotor
15%
disability
in
their
es5mates1
49%
Visual
Ø A
downward
revision
to
the
NSS
es5mate
of
locomotor
disability
57%
prevalence
to
~40%
would
exclude
(11)
dwarves
and
persons
with
s5ff
neck
28%
of
permanent
nature
that
may
not
Locomotor
(6)
need
assis5ve
aids/devices
Census
NSS
2001
2002
s5ff
neck,
and
inclusion
of
persons
having
mul5ple
disabili5es
under
each
category
may
be
responsible
for
the
large
varia5on
or
at
least
part
of
the
varia5on”
between
the
Census
and
NSS
es5mates
of
locomotor
disability
prevalence
rates
10
*Based
on
underlying
trend
analysis
of
causes
of
locomotor
disability
from
NSSO
and
Census
data
Locomotor
disability
prevalence
in
India:
Cause
analysis
Emerging
trends
in
causal
profile
of
locomotor
disability
We
es5mate
the
number
of
persons
with
locomotor
disability
(PwLD)
at
32.5m,
assuming
7%
total
disability
prevalence
as
men5oned
earlier
and
adjus5ng
for
recent
trends
in
underlying
causes
Non
communicable
diseases
include
Stroke,
Arthri5s,
Cerebral
Palsy,
Cancer,
Cardio-‐respiratory
disease;
Other
communicable
diseases
include
Tuberculosis
and
Leprosy;
Other
reasons
includes
Medical/surgical
interven5on.
For
2002,
Other
reasons
includes
Medical/surgical
interven5on,
other
illness,
not
known.
1World
Bank
(2009),
“People
with
Disabili5es
in
India:
From
Commitments
to
Outcomes”;
2Ministry
of
Sta5s5cs
&
Programme
Implementa5on,
GoI
(2011),
11
“Situa5on
Analysis
of
the
Elderly
in
India”;
3Indian
Council
of
Medial
Research
(2006),
“Workshop
Report
on
Stroke
Surveillance
in
India“
Locomotor
disability
prevalence
in
India:
Rural
–
urban
spread
by
cause
Break-‐up
of
PwLD
by
rural
–
urban
spread
and
cause
of
locomotor
disability
(2015)
Rural
Total
53%
(17.1m)
47%
(15.4m)
32.5m
Urban
PwLD
Accidents
57% 43% 15.5m
and
injuries
Non-‐
communicable
23%
77%
3.8m
diseases
Other
communicable
2%
98% 0.2m
diseases
Other
reasons
13% 87% 1.0m
Sources:
Na5onal
Sample
Survey,
58th
round
(2002);
Rural
prevalence
considered
at
68%
as
per
World
Bank
es5mates
for
2010-‐14
Non
communicable
diseases
include
Stroke,
Arthri5s,
Cerebral
Palsy,
Cancer,
Cardio-‐respiratory
disease;
Other
communicable
diseases
include
Tuberculosis
12
and
Leprosy;
Other
reasons
includes
Medical/surgical
interven5on.
Large
unmet
demand
for
assis4ve
aids/devices
for
PwLD
Prevalence
of
locomotor
disability
within
total
disabled
PwLDs’
inequitable
access
to
care
and
assis4ve
popula4on
devices1
84.7m
7%
32.5m
38%
13
1World
Bank
(2009),
“People
with
Disabili5es
in
India:
From
Commitments
to
Outcomes”
and
Na5onal
Sample
Survey,
58th
round
(2002)
Inability
to
afford
aids
is
the
primary
reason
why
1.6
million
PwLD
who
were
advised
did
not
acquire
assis4ve
aids
49%
22%
16%
8%
5%
14
Source:
Na5onal
Sample
Survey,
58th
round
(2002)
Five
million
PwLD
were
advised
and
acquired
assis4ve
aids
27%
0.9m
In
the
NSS
sample,
those
in
urban
areas
were
55%
17%
more
likely
to
have
sought
0.4m
1%
33%
treatment,
than
those
in
5%
rural
areas2
7%
11%
Cost
High
Private
cos.
(O7obock,
Small
market,
Endolite
India,
mostly
imported
Ostrich
Mobility,
players
VISSCO,
etc.)
Low
High
Quality
Innova5on
in
the
low
cost,
high
quality
space
has
overcome
affordability/
price
barriers
in
the
past.
An
opportunity
exists
both
to
create
new
innova5on
and
bring
exis5ng
innova5ons
to
scale.
Microinsurance
as
a
payment
mechanism
may
be
one
op5on
17
1Dalberg
interviews
The
bulk
of
the
BOP
space
is
met
by
free
distribu4on
Non
–
BoP
ALIMCO’s
customers
as
a
percentage
of
sales1
Na5onal
Ins5tutes
State
Govt.
4.46%
Direct
Purchases
24.24%
Sarva
Shiksha
Abhiyan
–
ADIP
Aids
are
not
covered
by
insurance
and
costs
must
be
borne
by
end
users
However,
ability
to
pay
is
not
a
constraint
since
aids
are
mostly
distributed
for
free.
The
primary
point
of
access
to
aids/devices
are
camps
conducted
by
ALIMCO
and
other
organiza5ons
ALIMCO
provides
low
cost,
low
quality
products
largely
for
free,
and
has
strong
distribu4on
channels
that
can
be
u5lized
to
ensure
last
mile
connec5vity
20
Source:
Icons
from
www.thenounproject.com
Key
insights
into
the
current
BoP
market:
Quality
and
innova4on
Some
important
challenges
are:
A
• Informa4on
dissemina4on
to
the
BoP
space
to
increase
awareness
about
assistance
schemes
and
type
of
aids/devices
available
1
• Scaling
up
exis5ng
distribu5on
channels
to
serve
a
larger
por5on
of
the
BoP
• Life
• While
customiza5on
is
feasible
for
high-‐end
products,
at
the
BOP-‐level
customiza4on,
ensuring
fit,
and
adap4ng
aids
for
outdoor
use
is
uncommon
Thus,
there
is
a
need
for
innova5ve
solu5ons
that
provide
the
BoP
with
assis5ve
aids/
devices
that
are
both
durable
and
customizable.
Examples
of
innova5ve
solu5ons
are
presented
on
the
next
slide
21
Source:
Icons
from
www.thenounproject.com
Innova4ve,
low-‐cost
technology
in
the
BoP
spaces:
Opportunity
set
The
Rs.
3,000
Jaipur
Foot
is
1/100th
the
cost
of
compe5ng
devices
and
a
comparable
limb
in
the
United
States
costs
$10,000
BMVSS
has
also
developed
the
Rs.
1,200
prosthe5c
knee,
in
partnership
with
Stanford
University1
Mobility
India
has
taken
the
Jaipur
Foot
further
by
developing
various
designs,
including
a
pediatric
version,
and
this
unit
is
managed
by
trained
women
technicians2
has
also
developed
pre-‐fabricated
components
of
ortho5c
and
It
prosthe5c
devices,
enabling
fabrica5on
and
fiyng
to
be
completed
in
the
same
day,
reducing
PwLD’s
5me
and
cost
spent
on
acquiring
devices
1Na5onal Sample Survey, 58th round (2002); 2Average life: Prosthe5c devices (hqp://jaipurfoot.org/images/BROCHURE.pdf), Calipers (Oqobock
Documenta5on
Requirements),
Braces
and
Splints
(Assump5on,
discussions
with
dealers),
Crutches
(Assump5on,
discussion
with
dealers),
Wheelchairs
(Meyra
Ortopedia
Opera5ng
Manual
for
Folding
Wheelchair)
and
Tricycles
(Assumed
same
as
average
life
of
wheelchair);
3Dalberg
interviews,
online
resources
-‐
Prosthe5c
devices
(Average
cost
of
upper
and
lower
extremity
devices
from
Jaipur
Foot
cost
sheet),
Calipers
and
Braces
(average
cost
from
ALIMCO
price
list
2014),
Splints
(average
of
VISSCO
and
Tynor
products
on
Amazon.in),
Personal
Mobility
Aids
(interview
with
ALIMCO);
4Others
category
of
23
assis5ve
aids/devices
(people
affected:
5.6M)
has
been
excluded
in
the
unaddressed
market
size
due
to
lack
of
informa5on
about
sub-‐components.
The
current
BoP
market
is
not
en4rely
met
by
exis4ng
large,
organized
players
Overview of BoP space of the annual current market (US$ 42m)1
24
1Calculated
as
70%
of
the
total
annual
current
market
Key
parameters
for
calcula4ng
annual
unaddressed
BoP
market
size
People
affected
1.9
3.0
0.3
1.4
9.0
2.2
1.6
19.4
(millions)
People
affected
0.6
0.6
0.3
1.4
6.0
0.5
0.4
9.9
annually
(millions)
1Na5onal Sample Survey, 58th round (2002); 2Average life: Prosthe5c devices (hqp://jaipurfoot.org/images/BROCHURE.pdf), Calipers (Oqobock
Documenta5on
Requirements),
Braces
and
Splints
(Assump5on,
discussions
with
dealers),
Crutches
(Assump5on,
discussion
with
dealers),
Wheelchairs
(Meyra
Ortopedia
Opera5ng
Manual
for
Folding
Wheelchair)
and
Tricycles
(Assumed
same
as
average
life
of
wheelchair);
3Dalberg
interviews,
online
resources
-‐
Prosthe5c
devices
(Average
cost
of
upper
and
lower
extremity
devices
from
Jaipur
Foot
cost
sheet),
Calipers
and
Braces
(average
cost
from
ALIMCO
price
list
2014),
Splints
(average
of
VISSCO
and
Tynor
products
on
Amazon.in),
Personal
Mobility
Aids
(interview
with
ALIMCO);
4Others
category
of
25
assis5ve
aids/devices
(people
affected:
5.6M)
has
been
excluded
in
the
unaddressed
market
size
due
to
lack
of
informa5on
about
sub-‐components.
The
annual
unaddressed
market,
which
represents
nearly
84%
of
PwLD,
is
es4mated
to
be
US$
316m
US$
57m
US$
48m
27
Source:
Dalberg
interviews
Summary:
Market
Sizing
Prevalence of Disability Type of disability Access to care Type of assis4ve aid
Prosthe4c
devices
0.6m
(US$
49m)
Visual
Annual
BoP
market
:
1.3m
Ar4ficial
Limbs
Advised
and
acquired
aids
/
devices
Ortho4c
devices
Hearing
With
2.3m
(US$
57m)
disability
Locomotor
Annual
BoP
market
:
9.9m
84.7M
Calipers
32.5M
Advised
and
not
acquired
Splints
aids
/
devices
Total
Speech
Spinal
Braces
Popula5on
Did
not
receive
medical
advice
Personal
Developmental
mobility
aids
6.9m
(US$
210m)
Without
disability
Crutches
Wheelchairs
Tricycles
28
Key
insights
to
serving
the
BoP
space
The
poten5al
market
size
for
assis5ve
aids/devices
is
large
and
aqrac5ve;
the
current
market
in
India
is
es5mated
to
be
US$
42m
and
the
unaddressed
market
is
es5mated
to
be
US$
316m
Crutches
and
wheelchairs
form
the
largest
segments
of
the
unaddressed
market
at
US
$
105M
and
US$
60m
respec5vely.
The
overall
unaddressed
market
is
evenly
split
between
urban
and
rural
areas,
at
approximately
US$
158m
each.
End
users'
ability
to
pay
by
is
low,
especially
without
insurance
coverage.
However,
robust
distribu5on
channels
exist
through
the
government,
NGOs
and
CSR
Case
studies
exist
of
innova5ve
low-‐cost
solu5ons
that
have
managed
to
be
sustainable
enterprises
(Jaipur
Foot,
Mo5va5on,
Mobility
India)
29
Source:
Icons
from
www.thenounproject.com
Global
market
for
assis4ve
aids/devices
for
PwLD
is
projected
to
be
US$
3.89nm
Prevalence
of
locomotor
disability
within
global
Global
projec4on
for
the
market
for
assis4ve
disabled
popula4on
aids/devices
based
on
the
Indian
market
US$ 316m
1.1bn
1.1bn
15%
400m
35%2
1United Na5ons, Department of Economic and Social Affairs, Popula5on Division, Popula5on Es5mates and Projec5ons Sec5on (hqp://esa.un.org/unpd/wpp/
unpp/p2k0data.asp)
30
2Global
prevalence
of
locomotor
disability
assumed
to
be
35%
Thank
You